Pharmacokinetics and cancer chemotherapy
- 31 December 1994
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (5), 706-710
- https://doi.org/10.1016/0959-8049(94)90550-9
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Statistical and Ethical Issues in the Design and Conduct of Phase I and II Clinical Trials of New Anticancer AgentsJNCI Journal of the National Cancer Institute, 1993
- Early Cancer Clinical Trials: Safety, Numbers, and ConsentJNCI Journal of the National Cancer Institute, 1993
- The relevance of pharmacology in clinical oncology practiceAnnals of Oncology, 1993
- The relevance of pharmacology in clinical oncology practiceAnnals of Oncology, 1993
- The relevance of pharmacology in clinical oncology practiceAnnals of Oncology, 1993
- The impact of pharmacokinetically guided dose escalation strategies in phase I clinical trials: Critical evaluation and recommendations for future studiesAnnals of Oncology, 1992
- Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentClinical Pharmacology & Therapeutics, 1992
- Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelinesEuropean Journal of Cancer and Clinical Oncology, 1987
- Development of quantitative structure-pharmacokinetic relationships.Environmental Health Perspectives, 1985
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977